PharmaShots | Incisive News in 3 Shots

Subscribe Now

Accord BioPharma

Accord BioPharma’s Hercessi 420mg (Biosimilar, Herceptin) Receives the US FDA’s Approval to Treat Various HER2-Overexpressing Cancer

Accord BioPharma’s Hercessi 420mg (Biosimilar, Herceptin) Receives the US FDA’s Approval to Treat Various HER2-Overexpressing Canc...

September 19, 2024

Accord BioPharma Reports US FDA’s Acceptance of BLA for DMB-3115 (Biosimilar, Stelara)

Accord BioPharma Reports US FDA’s Acceptance of BLA for DMB-3115 (Biosimilar, Stelara)

January 4, 2024

Accord BioPharma Reports the US FDA Acceptance of BLA for HLX02, a Proposed Trastuzumab Biosimilar for Gastric Cancer and Other Indications

Accord BioPharma Reports the US FDA Acceptance of BLA for HLX02, a Proposed Trastuzumab Biosimilar for Gastric Cancer and Other In...

April 5, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us